Brimonidine Eye Drops for Treatment of Ocular Graft-vs-Host Disease (oGVHD)

Clinical trial NCT02975557 · TERMINATED

Trial details

NCT number

NCT02975557

Sponsor

Sandeep Jain, MD

Status

TERMINATED

Phase

Phase 1, Phase 2

Study type

INTERVENTIONAL

Start date

2016-05-01

Primary completion

2017-04-13

Enrollment

15

View on ClinicalTrials.gov